TWI243162B
(en)
*
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
EP1404310A4
(fr)
*
|
2001-06-11 |
2005-01-12 |
Xenoport Inc |
Formes de dosage de promedicaments a faible toxicite a base d'analogues du gaba, administrees par voie orale
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US7196201B2
(en)
|
2001-06-27 |
2007-03-27 |
Smithkline Beecham Corporation |
Pyrrolidines as dipeptidyl peptidase inhibitors
|
CA2450722A1
(fr)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase
|
WO2003002553A2
(fr)
|
2001-06-27 |
2003-01-09 |
Smithkline Beecham Corporation |
Fluoropyrrolidines inhibitrices de la dipeptidyl peptidase
|
US7153822B2
(en)
*
|
2002-01-29 |
2006-12-26 |
Wyeth |
Compositions and methods for modulating connexin hemichannels
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
TW200401635A
(en)
|
2002-07-23 |
2004-02-01 |
Yamanouchi Pharma Co Ltd |
2-Cyano-4-fluoropyrrolidine derivative or salt thereof
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
EP1565437A1
(fr)
|
2002-11-18 |
2005-08-24 |
Pfizer Products Inc. |
Amides cycliques fluor s inhibant la dipeptidyl peptidase iv
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
WO2004099134A2
(fr)
*
|
2003-05-05 |
2004-11-18 |
Prosidion Ltd. |
Inhibiteurs de la dp iv a base de glutaminyle
|
NZ572274A
(en)
|
2003-05-05 |
2009-06-26 |
Probiodrug Ag |
Use of effectors of glutaminyl and glutamate cyclases
|
MXPA05011861A
(es)
|
2003-05-05 |
2006-02-17 |
Probiodrug Ag |
Uso de efectores de ciclasas de glutamato y glutaminil.
|
JP4806628B2
(ja)
|
2003-05-05 |
2011-11-02 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤
|
JP2006527194A
(ja)
*
|
2003-06-06 |
2006-11-30 |
メルク エンド カムパニー インコーポレーテッド |
糖尿病の治療又は予防のためのジペプチジルペプチダーゼ阻害剤としての縮合インドール
|
US6995183B2
(en)
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
WO2005019168A2
(fr)
*
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Derives fluores de lysine en tant qu'inhibiteurs de la dipeptidylpeptidase iv
|
CA2551037A1
(fr)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de piperidine
|
WO2005039548A2
(fr)
|
2003-10-15 |
2005-05-06 |
Probiodrug Ag |
Utilisation d'effecteurs de cyclases du glutaminyle et du glutamate
|
NZ546887A
(en)
|
2003-11-03 |
2009-04-30 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
CA2541212A1
(fr)
*
|
2003-11-04 |
2005-05-19 |
Wallace T. Ashton |
Derives de phenylalanine fusionnes utilises comme inhibiteurs de la dipeptidyl peptidase-iv dans le traitement ou la prevention du diabete
|
EP1686994A2
(fr)
|
2003-11-17 |
2006-08-09 |
Novartis AG |
Utilisation d'inhibiteurs de dipeptidyl-pepetidase iv
|
DK3023095T3
(en)
|
2004-01-20 |
2018-08-20 |
Novartis Ag |
Directly pressed wording and approach
|
CN1918131B
(zh)
|
2004-02-05 |
2011-05-04 |
前体生物药物股份公司 |
谷氨酰胺酰基环化酶抑制剂
|
JP2007530690A
(ja)
|
2004-03-29 |
2007-11-01 |
メルク エンド カムパニー インコーポレーテッド |
11−β−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのジアリールトリアゾール
|
EP1734963A4
(fr)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
Methode destinee a traiter des hommes presentant des troubles metaboliques et anthropometriques
|
PL1753748T3
(pl)
*
|
2004-05-12 |
2010-01-29 |
Pfizer Prod Inc |
Pochodne proliny i ich zastosowanie jako inhibitorów peptydazy dipeptylowej IV
|
CN1968949B
(zh)
*
|
2004-05-12 |
2011-05-04 |
辉瑞产品公司 |
脯氨酸衍生物和其作为二肽基肽酶iv抑制剂的用途
|
EP1756106A4
(fr)
*
|
2004-05-18 |
2008-12-17 |
Merck & Co Inc |
Derives de la cyclohexylalanine utilises comme inhibiteurs de la dipeptidyl peptidase-iv pour le traitement ou la prevention des diabetes
|
US7842707B2
(en)
|
2004-07-23 |
2010-11-30 |
Nuada, Llc |
Peptidase inhibitors
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
11−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−1の阻害剤としてのスルホニル化合物
|
US20060046978A1
(en)
*
|
2004-08-31 |
2006-03-02 |
Morphochem Ag |
Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
|
NZ554737A
(en)
|
2004-11-04 |
2011-04-29 |
Xenoport Inc |
Gabapentin prodrug sustained release oral dosage forms
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
JP2008024592A
(ja)
*
|
2005-01-28 |
2008-02-07 |
Taisho Pharmaceut Co Ltd |
シアノピロリジン誘導体含有固形製剤用組成物、それを含有する固形製剤及びその製造方法
|
TWI403511B
(zh)
*
|
2005-02-18 |
2013-08-01 |
Mitsubishi Tanabe Pharma Corp |
脯胺酸衍生物之鹽、或其溶媒合物,以及其製造方法
|
JP4568361B2
(ja)
|
2005-04-22 |
2010-10-27 |
アラントス・ファーマシューティカルズ・ホールディング・インコーポレーテッド |
ジペプチジルペプチダーゼ−iv阻害剤
|
AU2006253312B2
(en)
|
2005-05-30 |
2011-08-18 |
Msd K.K. |
Novel piperidine derivative
|
MY152185A
(en)
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
WO2007017423A2
(fr)
*
|
2005-08-11 |
2007-02-15 |
F. Hoffmann-La Roche Ag |
Composition pharmaceutique
|
DE602006017712D1
(de)
|
2005-08-24 |
2010-12-02 |
Banyu Pharma Co Ltd |
Phenylpyridonderivat
|
EP1760076A1
(fr)
|
2005-09-02 |
2007-03-07 |
Ferring B.V. |
Inhibiteur de FAP
|
CA2621470A1
(fr)
|
2005-09-07 |
2007-03-15 |
Banyu Pharmaceutical Co., Ltd. |
Derive de pyridone substitue aromatique bicylique
|
EP1942898B2
(fr)
|
2005-09-14 |
2014-05-14 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de la dipeptidyl peptidase permettant de traiter le diabete
|
KR101368988B1
(ko)
|
2005-09-16 |
2014-02-28 |
다케다 야쿠힌 고교 가부시키가이샤 |
디펩티딜 펩티다제 억제제
|
WO2007041052A2
(fr)
|
2005-09-29 |
2007-04-12 |
Merck & Co., Inc. |
Derives spiropiperidines acyles convenant comme modulateurs des recepteurs de la melanocortine-4
|
TW200730494A
(en)
*
|
2005-10-10 |
2007-08-16 |
Glaxo Group Ltd |
Novel compounds
|
DE602006015215D1
(de)
*
|
2005-10-10 |
2010-08-12 |
Glaxo Group Ltd |
Prolinamidderivate als natriumkanalmodulatoren
|
US8163770B2
(en)
|
2005-10-27 |
2012-04-24 |
Msd. K. K. |
Benzoxathiin derivative
|
NZ568292A
(en)
|
2005-11-10 |
2011-08-26 |
Msd Kk |
Spiro[cyclohexane-1,1'-(3'H)-4'-azaisobenzofuran]-4-carboxamide derivatives
|
GB0526291D0
(en)
|
2005-12-23 |
2006-02-01 |
Prosidion Ltd |
Therapeutic method
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
JP2009533393A
(ja)
|
2006-04-12 |
2009-09-17 |
プロビオドルグ エージー |
酵素阻害薬
|
CA2810522A1
(fr)
|
2006-05-04 |
2007-11-15 |
Boehringer Ingelheim International Gmbh |
Polymorphes
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
EP1852108A1
(fr)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Compositions d'inhibiteurs de la DPP IV
|
US8324383B2
(en)
|
2006-09-13 |
2012-12-04 |
Takeda Pharmaceutical Company Limited |
Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
|
US8173629B2
(en)
|
2006-09-22 |
2012-05-08 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
US20090247560A1
(en)
|
2006-09-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
WO2008055945A1
(fr)
|
2006-11-09 |
2008-05-15 |
Probiodrug Ag |
Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies
|
TW200838536A
(en)
|
2006-11-29 |
2008-10-01 |
Takeda Pharmaceutical |
Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
|
DK2091948T3
(da)
|
2006-11-30 |
2012-07-23 |
Probiodrug Ag |
Nye inhibitorer af glutaminylcyclase
|
US8093236B2
(en)
|
2007-03-13 |
2012-01-10 |
Takeda Pharmaceuticals Company Limited |
Weekly administration of dipeptidyl peptidase inhibitors
|
EP2145884B1
(fr)
|
2007-04-02 |
2014-08-06 |
Msd K.K. |
Dérivé d'indoledione
|
US8927504B2
(en)
|
2007-04-03 |
2015-01-06 |
Mitsubishi Tanabe Pharma Corporation |
Combined use of dipeptidyl peptidase 4 inhibitor and sweetener
|
EP2865670B1
(fr)
|
2007-04-18 |
2017-01-11 |
Probiodrug AG |
Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase
|
JP2010526807A
(ja)
|
2007-05-07 |
2010-08-05 |
メルク・シャープ・エンド・ドーム・コーポレイション |
抗糖尿病活性を有する縮合芳香族化合物を用いた治療法
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
CL2008003653A1
(es)
|
2008-01-17 |
2010-03-05 |
Mitsubishi Tanabe Pharma Corp |
Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
|
US20110015181A1
(en)
|
2008-03-06 |
2011-01-20 |
Makoto Ando |
Alkylaminopyridine derivative
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Msd株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
AR071175A1
(es)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
|
EP2146210A1
(fr)
|
2008-04-07 |
2010-01-20 |
Arena Pharmaceuticals, Inc. |
Procédés d'utilisation du récepteur couplé aux protéines A G pour identifier les secrétagogues de peptide YY (PYY) et composés utiles dans le traitement d'états modulés par PYY
|
EP3239170B1
(fr)
|
2008-06-04 |
2019-03-20 |
Synergy Pharmaceuticals Inc. |
Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
EP3241839B1
(fr)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonistes de guanylate cyclase utiles pour le traitement de troubles gastro-intestinaux, inflammatoires, cancéreux et autres
|
AU2009277736A1
(en)
|
2008-07-30 |
2010-02-04 |
Banyu Pharmaceutical Co., Ltd. |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
MX2011004258A
(es)
|
2008-10-22 |
2011-06-01 |
Merck Sharp & Dohme |
Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
|
US8592457B2
(en)
|
2008-10-30 |
2013-11-26 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
CA2741672A1
(fr)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Nouveaux agents antidiabetiques utiles avec des derives de benzimidazole cycliques
|
EP2358200A4
(fr)
|
2008-11-17 |
2012-05-16 |
Merck Sharp & Dohme |
Amines bicycliques substituées pour le traitement du diabète
|
CN101899048B
(zh)
*
|
2009-05-27 |
2013-04-17 |
上海恒瑞医药有限公司 |
(R)-7-[3-氨基-4-(2,4,5-三氟-苯基)-丁酰]-3-三氟甲基-5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸甲酯的盐
|
AR077642A1
(es)
|
2009-07-09 |
2011-09-14 |
Arena Pharm Inc |
Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo
|
WO2011011506A1
(fr)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Composés oxazépine spirocyclique en tant qu'inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
|
WO2011011508A1
(fr)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Composés doxazépine benzofusionnés en tant quinhibiteurs de la coenzyme-stéaroyle a delta-9 désaturase
|
CA2772488C
(fr)
|
2009-09-11 |
2018-04-17 |
Probiodrug Ag |
Derives heterocycliques en tant qu'inhibiteurs de glutaminyle cyclase
|
BR112012012641A2
(pt)
|
2009-11-27 |
2020-08-11 |
Boehringer Ingelheim International Gmbh |
TRATAMENTO DE PACIENTES DIABÉTICOS GENOTIPADOS COM INIBIDORES DE DPP-lVTAL COMO LINAGLIPTINA
|
CA2784799C
(fr)
|
2009-12-30 |
2014-06-10 |
Shanghai Fochon Pharmaceutical Co Ltd |
Certains inhibiteurs de la dipeptidylpeptidase
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
ES2586231T3
(es)
|
2010-03-03 |
2016-10-13 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
DK2545047T3
(da)
|
2010-03-10 |
2014-07-28 |
Probiodrug Ag |
Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
|
BR112012025592A2
(pt)
|
2010-04-06 |
2019-09-24 |
Arena Pharm Inc |
moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos
|
EP2560953B1
(fr)
|
2010-04-21 |
2016-01-06 |
Probiodrug AG |
Inhibiteurs de glutaminyl cyclase
|
CA2797310C
(fr)
|
2010-05-05 |
2020-03-31 |
Boehringer Ingelheim International Gmbh |
Therapie de combinaison de l'agoniste du recepteur glp-1 et de l'inhibiteur dpp-4
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
EP3323818A1
(fr)
|
2010-09-22 |
2018-05-23 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés
|
AR083878A1
(es)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
|
CN105001219A
(zh)
|
2011-02-25 |
2015-10-28 |
默沙东公司 |
用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物
|
DK2681236T3
(en)
|
2011-03-01 |
2018-04-16 |
Synergy Pharmaceuticals Inc |
PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS
|
DK2686313T3
(en)
|
2011-03-16 |
2016-05-02 |
Probiodrug Ag |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
US20140018371A1
(en)
|
2011-04-01 |
2014-01-16 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
US20140066369A1
(en)
|
2011-04-19 |
2014-03-06 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
US20140051714A1
(en)
|
2011-04-22 |
2014-02-20 |
Arena Pharmaceuticals, Inc. |
Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
|
WO2012145603A1
(fr)
|
2011-04-22 |
2012-10-26 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles liés à celui-ci
|
WO2012170702A1
(fr)
|
2011-06-08 |
2012-12-13 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés à celui-ci
|
US8962636B2
(en)
|
2011-07-15 |
2015-02-24 |
Boehringer Ingelheim International Gmbh |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
WO2013055910A1
(fr)
|
2011-10-12 |
2013-04-18 |
Arena Pharmaceuticals, Inc. |
Modulateurs du récepteur gpr119 et traitement de troubles associés
|
AR088352A1
(es)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
Antagonistas del receptor de 2-piridiloxi-4-nitrilo orexina
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2849755A1
(fr)
|
2012-05-14 |
2015-03-25 |
Boehringer Ingelheim International GmbH |
Dérivé de xanthine en tant qu'inhibiteur de dpp-4 pour l'utilisation dans le traitement de troubles associés aux podocytes et/ou un syndrome néphrotique
|
WO2013174767A1
(fr)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
WO2014074668A1
(fr)
|
2012-11-08 |
2014-05-15 |
Arena Pharmaceuticals, Inc. |
Modulateurs de gpr119 et traitement de troubles associés à ceux-ci
|
JP2016516004A
(ja)
|
2013-02-22 |
2016-06-02 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗糖尿病二環式化合物
|
US9650375B2
(en)
|
2013-03-14 |
2017-05-16 |
Merck Sharp & Dohme Corp. |
Indole derivatives useful as anti-diabetic agents
|
CA2905435A1
(fr)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions utiles pour le traitement de troubles gastro-intestinaux
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
EP3004138B1
(fr)
|
2013-06-05 |
2024-03-13 |
Bausch Health Ireland Limited |
Agonistes ultra-purs de guanylate cyclase c, leur procédé de production et d'utilisation
|
WO2015051496A1
(fr)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Composés tricycliques antidiabétiques
|
WO2015128453A1
(fr)
|
2014-02-28 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Utilisation médicale d'un inhibiteur de dpp-4
|
CN113121450A
(zh)
|
2014-08-29 |
2021-07-16 |
Tes制药有限责任公司 |
α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
|
GB201415598D0
(en)
|
2014-09-03 |
2014-10-15 |
Univ Birmingham |
Elavated Itercranial Pressure Treatment
|
ES2912881T3
(es)
|
2014-12-23 |
2022-05-30 |
Convergence Pharmaceuticals |
Procedimiento para preparar derivados de alfa-carboxamida pirrolidina
|
AU2016229982B2
(en)
|
2015-03-09 |
2020-06-18 |
Intekrin Therapeutics, Inc. |
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
|
KR20170001885U
(ko)
|
2015-11-20 |
2017-05-30 |
대우조선해양 주식회사 |
돌극형 발전기의 회전자 코일 휨 방지장치
|
EP4233840A3
(fr)
|
2016-06-10 |
2023-10-18 |
Boehringer Ingelheim International GmbH |
Combinaisons de linagliptine et de metformine
|
CA3038185A1
(fr)
|
2016-10-14 |
2018-04-19 |
Tes Pharma S.R.L. |
Inhibiteurs de la semialdehyde decarboxylase de l'acide alpha-amino-beta-carboxymuconique
|
WO2018106518A1
(fr)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Composés hétérocycliques antidiabétiques
|
WO2018118670A1
(fr)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Composés de spirochromane antidiabétiques
|
JP2020515639A
(ja)
|
2017-04-03 |
2020-05-28 |
コヒラス・バイオサイエンシズ・インコーポレイテッド |
進行性核上性麻痺の処置のためのPPARγアゴニスト
|
PL3461819T3
(pl)
|
2017-09-29 |
2020-11-30 |
Probiodrug Ag |
Inhibitory cyklazy glutaminylowej
|
MA50630A
(fr)
|
2017-10-05 |
2021-03-31 |
Biogen Inc |
Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine
|
JP2021506972A
(ja)
|
2017-12-15 |
2021-02-22 |
プラクシス バイオテック エルエルシー |
線維芽細胞活性化タンパク質の阻害剤
|
KR20210111248A
(ko)
|
2018-11-20 |
2021-09-10 |
테스 파마 에스.알.엘. |
α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제
|
EP3924058A1
(fr)
|
2019-02-13 |
2021-12-22 |
Merck Sharp & Dohme Corp. |
Agonistes du récepteur de l'orexine 5-alkyl-pyrrolidine
|
US20230018413A1
(en)
|
2019-08-08 |
2023-01-19 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
IL300610A
(en)
|
2020-08-18 |
2023-04-01 |
Merck Sharp ַ& Dohme Llc |
Bicycloheptane pyrrolidine compounds are orexin receptor agonists
|
CN115368344A
(zh)
*
|
2022-08-22 |
2022-11-22 |
湖北科技学院 |
组氨酸类衍生物及其制备方法和应用
|